tiprankstipranks
Advertisement
Advertisement

INDP Stock Latest News

Indaptus Therapeutics Adds Independent Directors Amid Board Refresh
Company AnnouncementsIndaptus Therapeutics Adds Independent Directors Amid Board Refresh
12d ago
8K
INDP
Indaptus Therapeutics Names New CFO, Refreshes Board Oversight
PremiumCompany Announcements
Indaptus Therapeutics Names New CFO, Refreshes Board Oversight
1M ago
8K
INDP
Indaptus Therapeutics Announces Major Leadership and Board Changes
PremiumCompany Announcements
Indaptus Therapeutics Announces Major Leadership and Board Changes
1M ago
8K
INDP
Indaptus Shareholders Approve Major Charter and Capital Changes
PremiumCompany Announcements
Indaptus Shareholders Approve Major Charter and Capital Changes
2M ago
8K
INDP
Indaptus Therapeutics Reprices Warrants to Bolster Shareholder Support
PremiumCompany Announcements
Indaptus Therapeutics Reprices Warrants to Bolster Shareholder Support
3M ago
8K
INDP
Indaptus Therapeutics cuts executive pay, director stays on
PremiumCompany AnnouncementsIndaptus Therapeutics cuts executive pay, director stays on
3M ago
8K
INDP
Indaptus Therapeutics Appoints David Natan to Board
Premium
Company Announcements
Indaptus Therapeutics Appoints David Natan to Board
4M ago
8K
INDP
Indaptus Therapeutics announces upcoming board leadership transition
Premium
Company Announcements
Indaptus Therapeutics announces upcoming board leadership transition
4M ago
8K
INDP
Indaptus Therapeutics enters $6M securities purchase agreement with David Lazar
PremiumThe Fly
Indaptus Therapeutics enters $6M securities purchase agreement with David Lazar
4M ago
INDP
Indaptus Therapeutics secures new funding and leadership shift
PremiumCompany Announcements
Indaptus Therapeutics secures new funding and leadership shift
4M ago
8K
INDP
Indaptus Therapeutics reports Q3 EPS ($2.98) vs ($9.04) last year
PremiumThe Fly
Indaptus Therapeutics reports Q3 EPS ($2.98) vs ($9.04) last year
6M ago
INDP
Indaptus Therapeutics Advances Cancer Treatment with DECOY20 Clinical Study
PremiumCompany Announcements
Indaptus Therapeutics Advances Cancer Treatment with DECOY20 Clinical Study
6M ago
INDP
Indaptus Therapeutics Reports Mixed Results in Clinical Trial
PremiumCompany AnnouncementsIndaptus Therapeutics Reports Mixed Results in Clinical Trial
8M ago
8K
INDP
Indaptus Therapeutics provides update on INDP-D101 clinical trial
Premium
The Fly
Indaptus Therapeutics provides update on INDP-D101 clinical trial
8M ago
INDP
Indaptus Therapeutics files to sell 781,250 shares of common stock, warrants
Premium
The Fly
Indaptus Therapeutics files to sell 781,250 shares of common stock, warrants
8M ago
INDP
Indaptus Therapeutics files $200M mixed securities shelf
PremiumThe Fly
Indaptus Therapeutics files $200M mixed securities shelf
9M ago
INDP
Indaptus Therapeutics files to sell 2.16M shares of common stock for holders
PremiumThe Fly
Indaptus Therapeutics files to sell 2.16M shares of common stock for holders
9M ago
INDP
Indaptus Therapeutics reports Q2 EPS ($9.09) vs ($13.16) last year
PremiumThe Fly
Indaptus Therapeutics reports Q2 EPS ($9.09) vs ($13.16) last year
9M ago
INDP
Indaptus Therapeutics Secures Approval for Private Placement
PremiumCompany Announcements
Indaptus Therapeutics Secures Approval for Private Placement
9M ago
8K
INDP
Indaptus Regains Nasdaq Compliance with Bid Price
PremiumCompany AnnouncementsIndaptus Regains Nasdaq Compliance with Bid Price
10M ago
8K
INDP
Indaptus Therapeutics Raises $5.7M for R&D Initiatives
Premium
Company Announcements
Indaptus Therapeutics Raises $5.7M for R&D Initiatives
10M ago
8K
INDP
Indaptus Therapeutics announces additional sale of $3.4M in private placement
Premium
The Fly
Indaptus Therapeutics announces additional sale of $3.4M in private placement
10M ago
INDP

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >